Artrya lands $15m for heart disease detection platform
Medical technology business Artyra (ASX: AYA) has pocketed $15 million from a placement to professional or sophisticated investors as it looks to fast track the commercialisation of its patented Salix artificial intelligence (AI) platform used to detect heart disease.
More specifically, the proceeds will be used to accelerate regulatory applications for its Salix Coronary Plaque (SCP) and Salix Coronary Flow (SCF) products, customer implem... moreArtrya lands $15m for heart disease detection platform
Medical technology business Artyra (ASX: AYA) has pocketed $15 million from a placement to professional or sophisticated investors as it looks to fast track the commercialisation of its patented Salix artificial intelligence (AI) platform used to detect heart disease.
More specifically, the proceeds will be used to accelerate regulatory applications for its Salix Coronary Plaque (SCP) and Salix Coronary Flow (SCF) products, customer implementation, clinical studies, regulatory costs, as well as research and development initiatives. https://thestocknetwork.com.au/videos/artrya-lands-15m-for-heart-disease-detection-platform/
